Neuro-Oncology Reviews
Volume
11 Number 7
31 July 2009
Home > Publications > Neuro-Oncology Reviews > Volume 11 Year 2009 > Number 7, 31 July
*Moiyadi A, Sridhar E, Jalali R.
Intraventricular
gliosarcoma: unusual location of an uncommon tumor.
J
Neurooncol. 2009 Jul 4;96(2):291-4. doi:
10.1007/s11060-009-9952-y. PMID:
19575149. Case report, Review. ˍ
Desjardins A, Reardon DA, Vredenburgh JJ.
Current
available therapies and future
directions in the treatment of malignant gliomas.
Biologics.
2009 Jul 13;3:15-25. doi:
10.2147/BTT.S3098. PMID:
19707392. Review. ˍ
*Kast RE.
Why cerebellar glioblastoma
is rare and how that indicates adjunctive use of the FDA-approved
anti-emetic aprepitant might retard cerebral glioblastoma growth:
a new hypothesis to an old question.
Clin
Transl Oncol. 2009 Jul 15;11(7):408-10. doi:
10.1007/s12094-009-0379-x. PMID:
19574198. Perspective. ˍ
Naydenov E, Bussarsky V, Nachev S,
Hadjidekova S, Toncheva D.
Long-Term
Survival of a Patient with Giant Cell Glioblastoma: Case Report
and Review of the Literature.
Case
Rep Oncol. 2009
Jul 17;2(2):103-110. doi:
10.1159/000228545. PMID:
20740171. Case report, Review. ˍ
*Bredel M.
Translating biological
insights into clinical endpoints in neuro-oncology.
Lancet
Oncol. 2009 Jul 21;10(10):928-9. doi:
10.1016/S1470-2045(09)70192-5. PMID:
19628430. Perspective. ˍ
*Addeo R, De Santi MS, Del Prete S, Caraglia M.
Fotemustine
and recurrent glioblastoma: possible new opportunities for an old
drug.
Cancer
Chemother Pharmacol. 2009 Jul 29;64(5):863-6. doi:
10.1007/s00280-009-1086-6. PMID:
19639315. Editorial. ˍ
*Piepmeier JM.
The future of
neuro-oncology.
Acta
Neurochir (Wien). 2009 Jul 29;151(11):1343-8. doi:
10.1007/s00701-009-0471-6. PMID:
19639245. Editorial. ˍ